Meet the team

Casey Paleos, MD

portrait of CASEY PALEOS, MD against a green background

Psychiatrist, Psychedelic Expert

Dr. Casey Paleos is a board-certified psychiatrist with well over 12 years of experience as a leader in ketamine and other psychedelic medicines in both research and clinical settings. A Co-Principal Investigator for the NYU-Bellevue Ketamine for Depression Study, Dr. Paleos was one of the early researchers to identify ketamine as a breakthrough treatment for depression. As a clinician, he has been treating patients for depression and anxiety using ketamine therapy in his New York private practice since 2016. In addition to his work with ketamine, Dr. Paleos has helped advance research in other areas of psychedelic medicine. Today, he serves as a Co-Principal Investigator for the MAPS-sponsored MDMA-Assisted Psychotherapy for PTSD Phase 3 Clinical Trials. Previously, he was a Co-Principal Investigator for the MDMA-Assisted Psychotherapy Phase 2 Clinical Trials and a Study Therapist for the NYU Psilocybin Cancer Anxiety Study.
He previously served as the Medical Director at Mindbloom and is a co-founder of Nautilus Sanctuary in New York City

Meet Our Next Advisory Board Member

Eugene Lipov, MD

Pioneer, DSB for PTSD